• 1
    Seligsohn U, Bolton-Maggs PHB. Factor XI deficiency. In: Lee CA, Berntorp EE, Hoots WK, eds. Textbook of Hemophilia. Second edition. Oxford: Wiley-Blackwell, 2010: 35561.
  • 2
    Blencowe BJ. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem Sci 2000; 25: 10610.
  • 3
    Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002; 3: 28598.
  • 4
    Zahler AM, Lane WS, Stolk JA, Roth MB. SR proteins: a conserved family of pre-mRNA splicing factors. Genes Dev 1992; 6: 83747.
  • 5
    Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acid Res 2003; 31: 356871.
  • 6
    Ben Rebeh I, Moriniere M, Ayadi L, Benzina Z, Charfedine I, Feki J, Ayadi H, Ghorbel A, Baklouti F, Masmoudi S. Reinforcement of a minor alternative splicing event in MYO7A due to a missense mutation results in a mild form of retinopathy and deafness. Mol Vis 2010; 16: 1898906.
  • 7
    Reese MG, Eeckeman FH, Kulp D, Haussler D. Improved splice site detection in Genie. J Comput Biol 1997; 4: 31123.
  • 8
    Asselta R, Rimoldi V, Guella I, Solda G, De Cristofaro R, Peyvandi F, Duga S. Molecular characterization of in-frame and out-of-frame alternative splicings in coagulation factor XI pre-mRNA. Blood 2010; 115: 206572.
  • 9
    Zivelin A, Bauduer F, Koronbrot N, Ducout L, Rosenberg N, Seligsohn U. Identification of 5 novel factor XI mutations in French Basques [abstract]. Haematologica 1999; 84(Suppl. 2): 0549.
  • 10
    Quelin F, Trossaert M, Sigaud M, Mazancourt PD, Fressinaud E. Molecular basis of severe factor XI deficiency in seven families from the west of France. Seven novel mutations, including an ancient Q88X mutation. J Thromb Haemost 2004; 2: 716.
  • 11
    Quelin F, Francois D, d’Oiron R, Guillet B, de Raucourt E, de Mazancourt P. Factor XI deficiency: identification of six novel missense mutations (P23L, P69T, C92G, E243D, W497C and E547K). Haematologica 2005; 90: 114950.
  • 12
    Hill M, McLeod F, Frank H, Gordon B, Dolan G. Genetic analysis in FXI deficiency: six novel mutations and the use of a polymerase chain reaction-based test to define a whole gene deletion. Br J Haematol 2005; 129: 8259.
  • 13
    Quelin F, Mathonnet F, Potentini-Esnault C, Trigui N, Peynet J, Bastenaire B, Guillon L, Bigel ML, Sauger A, Mazurier C, de Mazancourt P. Identification of five novel mutations in the factor XI gene (F11) of patients with factor XI deficiency. Blood Coagul Fibrinolysis 2006; 17: 6973.
  • 14
    Karimi M, Jafari H, Lahsaeizadeh S, Afrasiabi A, Akbari A, Dehbozorgian J, Ardeshiri R, Guella I, Asselta R, Peyvandi F. Factor XI deficiency in Southern Iran: identification of a novel missense mutation. Ann Hematol 2009; 88: 35963.
  • 15
    Quelin F, Frere C, Pouymayou C, Morange P, de Mazancourt P, Juhan-Vague I. Prospective analysis of factor XI deficiencies in the Maseilles area identified four novel mutations among 12 consecutive unrelated families. Blood Coagul Fibrinolysis 2009; 20: 848.
  • 16
    Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
  • 17
    Zucker M, Zivelin A, Landau M, Salomon O, Kenet G, Bauduer F, Samama M, Conard J, Denninger MH, Hani AS, Berruyer M, Feinstein D, Seligsohn U. Characterization of seven novel mutations causing factor XI deficiency. Haematologica 2007; 92: 137580.
  • 18
    Zucker M, Zivelin A, Landau M, Rosenberg N, Seligsohn U. Three residues at the interface of factor XI (FXI) monomers augment covalent dimerization of FXI. J Thromb Haemost 2009; 7: 9705.
  • 19
    Jayo A, Pabon D, Lastres P, Jimenez-Yuste V, Gonzales-Manchon C. Type II Glanzmann thrombasthenia in a compound heterozygote for the alpha IIb gene. A novel missense mutation in exon 27. Haematologica 2006; 91: 13529.
  • 20
    Liu HX, Zhang M, Krainer AR. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev 1998; 12: 19982012.
  • 21
    Nowak DG, Woolard J, Amin EM, Konopatskaya O, Saleem MA, Churchill AJ, Ladomery MR, Harper SJ, Bates DO. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J call Sci 2008; 121: 348795.
  • 22
    Liu HX, Cartegni L, Zhang MQ, Krainer AR. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 2001; 27: 558.
  • 23
    Cartegni L, Krainer AR. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 2002; 30: 37784.
  • 24
    Gorlov IP, Gorlova OY, Frazier ML, Amos CI. Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers. Am J Hum Genet 2003; 73: 115761.
  • 25
    Caputi M, Kendzior RJ Jr, Beemon KL. A nonsense mutation in the fibrillin-1 gene of a Marfan syndrome patient induces NMD and disrupts an exonic splicing enhancer. Genes Dev 2002; 16: 17549.
  • 26
    Asselta R, Duga S, Spena S, Peyvandi F, Castaman G, Malcovati M, Mannucci PM, Tenchini ML. Missense or splicing mutation? The case of a fibrinogen Bbeta-chain mutation causing severe hypofibrinogenemia. Blood 2004; 103: 30514.
  • 27
    Xie J, Pabon D, Jayo A, Butta N, Gonzalez-Manchon C. Type I Glanzmann thrombasthenia caused by an apparently silent β3 mutation that results in aberrant splicing and reduced β3 mRNA. Thromb Haemost 2005; 93: 897903.
  • 28
    Peretz H, Rosenberg N, Landau M, Usher S, Nelson EJ, Mor-Cohen R, French DL, Mitchell BW, Nair SC, Chandy M, Coller BS, Srivastava A, Seligsohn U. Molecular diversity of Glanzmann Thrombasthenia in southern India: new insights into mRNA splicing and structure – function correlations of αIIbβ3 integrin (ITGA2B, ITGB3). Hum Mutat 2006; 27: 35969.
  • 29
    Tardos JG, Eisenreich A, Deikus G, Bechhofer DH, Chandras S, Zafar U, Rauch U, Bogdanov VY. SR proteins ASF/SF2 and SRp55 participate in tissue factor biosynthesis in human monocytic cells. J Thromb Haemost 2008; 6: 87784.
  • 30
    Pagani F, Buratti E, Stuani C, Baralle FE. Missense, nonsense and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9. J Biol chem 2003; 278: 265808.
  • 31
    Jallu V, Dusseaux M, Panzer S, Torchet MF, Hezard N, Goudemand J, de Brevern AG, Kaplan C. AlphaIIbbeta3 integrin: new allelic variants in Glanzmann thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing, expression and structure-function. Hum Mutat 2010; 31: 23746.
  • 32
    Meijers JCM, Davie EW, Chung DW. Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency. Blood 1992; 79: 143540.
  • 33
    Zivelin A, Bauduer F, Ducout L, Peretz H, Rosenberg N, Yatuv R, Seligsohn U. Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood 2002; 99: 244854.
  • 34
    Kravtsov DV, Monahan PE, Gailani D. A classification system for cross-reactive material-negative factor XI deficiency. Blood 2005; 105: 46713.
  • 35
    Mitchell MJ, Dai L, Clarke JB, Bolton-Maggs PHB, Savidge GF, Alhaq A. Characterization of five factor XI mutations. Thromb Haemost 2007; 97: 8849.